Phase II trial of menogaril in adenocarcinoma of the pancreas. A Southwest Oncology Group study

Invest New Drugs. 1991 Feb;9(1):77-8. doi: 10.1007/BF00194550.
No abstract available

Publication types

  • Clinical Trial
  • Multicenter Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adult
  • Aged
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Drug Evaluation
  • Female
  • Humans
  • Infusions, Intravenous
  • Male
  • Menogaril
  • Middle Aged
  • Nogalamycin / administration & dosage
  • Nogalamycin / adverse effects
  • Nogalamycin / analogs & derivatives*
  • Nogalamycin / therapeutic use
  • Pancreatic Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents
  • Menogaril
  • Nogalamycin